Industry Advisory Board Members
Dr. Dani P. Bolognesi, Ph.D.
Dr.Bolognesi is a co-founder, and former Chief Scientific Officer, Vice Chairman and member of the Board of Directors of Trimeris Inc. He played a major role in the company's development since its inception. From 1999 to 2003, he served as Chief Executive Officer of Trimeris which more
Robert R. Bonczek, J.D.
Mr. Bonczek is co-founder, President & CFO of b3 bio, inc. He was former Chief Financial Officer
and General Counsel of Trimeris Inc. Mr. Bonczek is also co-founder and President of AspenTree Capital. He has also been a consultant to Wilmer, Cutler, Pickering, Hale & Dorr, a major
more
Peter R. Dolan
Mr. Dolan is former Chief Executive Officer and Chairman of Gemin X Pharmaceuticals, Inc, a Fund I portfolio company acquired by Cephalon in April 2011. Prior to Gemin X, Mr. Dolan was Chairman and Chief Executive Officer of Bristol-Myers Squibb from 2001 to 2006. more
Dr. Henry A. McKinnell, Ph.D.
Henry (Hank) McKinnell retired as chairman and chief executive officer of Pfizer, Inc, in 2006, after originally joining in Tokyo in 1971. Over the years, he held positions of increasing responsibility around the world, including service as president of Pfizer Asia, based more
Mr. Leland F. Wilson
Leland F. Wilson has served as a Director since April 1991 and as Chief Executive Officer since November 1991 of Vivus, Inc. Mr. Wilson also served as President from April 1991 until October 2009. Prior to joining Vivus, Mr. Wilson was Vice President of Marketing and Corporate more
RECENT VALENCE NEWS
May 22, 2020
CalciMedica Raises $15 Million in Series C Financing Round Led by Valence Life Sciences
May 20, 2020
Atea Pharmaceuticals Announces IND Clearance of AT-527 for COVID-19 and $215 Million Financing
January 23, 2020
December 9, 2019